Rankings/Automata
Automata logo

Automata

WashedAI NativePrivateUpdated November 15, 2026

A legacy robotics and RPA vendor rebranding as AI automation without the underlying investment.

Founded
2015
CEO
Mostafa ElSayed
HQ
London, United Kingdom
Stage
Private
Revenue
Not disclosed
Total Funding
$177M
Employees
11-50
Flag a data issue
AI Platforms
33.9Bluescore
Momentum53.4
Market MapEarly Stage
Rank change (7d)▼ 14

Executive Summary

Updated Nov 12, 2026

What they do

  • Builds LINQ, a modular robotic lab bench plus orchestration software
  • Automates end-to-end wet-lab workflows for pharma, biotech and research labs
  • Connects lab hardware and data to AI models, including via MCP

Why it matters

  • Reports five top-pharma customers with repeat deployments driving growth
  • $45M Series C in 2026 led by Dimension, with Danaher Ventures
  • Beckman Coulter and CellVoyant partnerships push toward closed-loop, AI-guided experimentation

Best fit

  • Pharma and biotech R&D labs scaling high-throughput or cell-based workflows
  • CROs wanting walkaway automation across multi-instrument, end-to-end processes
  • Teams building AI-driven discovery that needs programmable, data-connected wet labs

Watch-outs

  • Hardware-heavy deployments mean significant capex, lab space and integration effort
  • Danaher ties may favour Beckman instruments over other vendors' ecosystems
  • Closed-loop AI experimentation features are new and lightly proven at scale

Products & Offerings

LINQ Platform

Integrated lab automation platform that combines modular robotic benches with orchestration software and AI-ready data architecture.

PlatformEnterpriseFlagship2023

LINQ Cloud

Cloud software for designing, testing, scheduling and managing automated lab workflows remotely across connected workcells.

PlatformEnterpriseCore Platform2023

LINQ Bench

Lab-bench-sized modular hardware system with integrated robotics and labware transport that hosts third-party instruments.

InfrastructureEnterpriseLive2023

LINQ Canvas

No-code, node-based workflow builder for creating and changing automated lab protocols.

Developer ToolEnterpriseLive

LINQ Run Manager

Run-management software for parallel workflow execution, live monitoring and real-time error handling.

PlatformEnterpriseLive
Analyst VerdictEvaluate

Updated Nov 12, 2026

Automata is a credible, well-funded specialist in integrated lab automation, with top-pharma customers and strategic backing from Danaher. Pharma, biotech and CRO buyers modernising wet-lab workflows should run a structured evaluation against Biosero, HighRes Biosolutions and the big instrument makers' automation offerings. Test claims of instrument openness and of AI or closed-loop capability on your own workflows. It is not a general enterprise AI platform and suits only life-sciences lab use cases.

Signal Provenance

Latest observation date and source for each signal category

Signal CategoryLast UpdatedSource
Funding Signals
Last funding round, Funding stage
Nov 15, 2026Cited web research
Hiring Velocity
Headcount, Headcount growth
Nov 9, 2026Research agents (estimate)
Technical Output
Research papers, GitHub activity
Nov 15, 2026Hugging Face Hub + news feed + research agents
News Sentiment
News mentions, News sentiment
Nov 15, 2026Verified news feed
Partnership Signals
Enterprise partnerships, Distribution partners
Nov 12, 2026Research agents (estimate)
Revenue Indicators
ARR estimate, Revenue growth
Nov 15, 2026Research agents (estimate)
Leadership Signals
CEO tenure, Founder-led
Oct 19, 2026Research agents (estimate)
Competitive Position
Category rank, Market share
NeverResearch agents (estimate)

Why this Bluescore?

6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology

Automata's Bluescore of 33.9 rests most on Customer Adoption (5.2, 50th percentile). Its weakest area is Product Depth (1.9, 2nd percentile).

In plain English

Automata's Bluescore of 33.9 out of 100 places it at #237 of 247 ranked companies, helped mainly by Business Model & Revenue, which adds 9.2 of 21 points, and Customer Adoption, which adds 6.8 of 13 points. Product Depth is the biggest drag: it scores 1.9 of 10, sits at the 2nd percentile among the AI250, and adds only 3.9 of 21 points with 17.1 left. Because Product Depth carries a 21% weight and has the most points still unclaimed, improving it would likely move the Bluescore more than any other dimension.

Written by AI from the scores below and checked against them; updated nightly.

D1 · Business Model & Revenue (21%)
4.4
+9.2 of 21 pts · 45th pct
D2 · Product Depth (21%)
1.9
+3.9 of 21 pts · 2nd pct
D3 · Data & Model Moat (19%)
3.5
+6.6 of 19 pts · 22nd pct
D4 · Talent & Research (16%)
2.6
+4.1 of 16 pts · 26th pct
D5 · Customer Adoption (13%)
5.2
+6.8 of 13 pts · 50th pct
D6 · Investment Momentum (10%)
3.1
+3.2 of 10 pts · 23rd pct

Risks

Updated Nov 12, 2026

Danaher strategic alignment could reduce neutrality toward non-Danaher instrument vendors
Medium
Smaller scale than Thermo Fisher, Hamilton and other entrenched lab-automation incumbents
Medium
Capital-intensive hardware deployments make switching costly once workflows are built
Medium
AI-ready and closed-loop experimentation claims still early, with limited independent validation
Medium
Venture-funded private company; continued growth depends on further deployment-led revenue
Low
Feedback